2C-T-31, also known as 2,5-dimethoxy-4-(4-trifluoromethylbenzylthio)phenethylamine, is a serotonin receptor modulator of the phenethylamine and 2C families. Its properties and effects in humans do not appear to be known. The drug shows affinity for the serotonin 5-HT2A receptor (Ki = 3.8–28nM) and much lower affinity for the serotonin 5-HT1A and 5-HT2C receptors (Ki = 1,063nM and 157nM, respectively). It is a very weak partial agonist or antagonist of the serotonin 5-HT2A receptor ( () = 53nM (2.8%)) and a moderate-efficacy but very-low-potency partial agonist of the serotonin 5-HT2B receptor ( () = 3,309nM (44%)). It also shows weak affinity for a number of other targets. The chemical synthesis of 2C-T-31 has been described. 2C-T-31 was first described in the scientific literature by Daniel Trachsel in 2003.
See also 2C (psychedelics) 2C-T-27 and 2C-T-33
References
External links 2C-T-31 - Isomer Design